Back to Octagon Capital Advisors LP
Q3 2026 13F filing
Updated 6 days ago26 disclosed positions worth $750.6M
Portfolio value
$750.6M
Total holdings
26
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-16
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | D DIANTHUS THERAPEUTICS INC | $148.5M | 1.69M | 19.79% | — |
| 2 | A ABIVAX SA | $98.3M | 993.0K | 13.10% | — |
| 3 | D DEFINIUM THERAPEUTICS INC | $95.6M | 2.51M | 12.73% | — |
| 4 | C COGENT BIOSCIENCES INC | $75.2M | 2.35M | 10.02% | — |
| 5 | A ARRIVENT BIOPHARMA INC | $64.8M | 2.14M | 8.64% | — |
| 6 | T TAYSHA GENE THERAPIES INC | $47.2M | 9.69M | 6.29% | — |
| 7 | O OBSIDIAN THERAPEUTICS INC | $33.2M | 2.41M | 4.42% | — |
| 8 | K KYMERA THERAPEUTICS INC | $22.9M | 205.0K | 3.05% | — |
| 9 | I DISC MEDICINE INC | $17.7M | 270.0K | 2.35% | — |
| 10 | T TANGO THERAPEUTICS INC | $15.7M | 630.0K | 2.09% | — |
| 11 | X XENON PHARMACEUTICALS INC | $15.6M | 420.0K | 2.08% | — |
| 12 | A ADLAI NORTYE GROUP LTD | $15M | 934.7K | 1.99% | — |
| 13 | M MIRUM PHARMACEUTICALS INC | $14.5M | 169.4K | 1.93% | — |
| 14 | A AKTIS ONCOLOGY INC | $13.9M | 713.0K | 1.85% | — |
| 15 | ? N/A PALISADE BIO INC | $13.9M | 10.28M | 1.85% | — |
| 16 | ? N/A ERASCA INC | $10.6M | 720.0K | 1.41% | — |
| 17 | B BIOAGE LABS INC | $9.2M | 1.30M | 1.23% | — |
| 18 | P PHARVARIS N V | $7.9M | 249.0K | 1.05% | — |
| 19 | ? N/A GYRE THERAPEUTICS INC | $7M | 954.4K | 0.93% | — |
| 20 | D DBV TECHNOLOGIES S A | $6.8M | 574.2K | 0.90% | — |
| 21 | O OCULAR THERAPEUTIX INC | $4.6M | 599.9K | 0.61% | — |
| 22 | T TREVI THERAPEUTICS INC | $4.5M | 315.0K | 0.60% | — |
| 23 | F FAETH THERAPEUTICS INC | $3M | 100.0K | 0.40% | — |
| 24 | D PRECISION BIOSCIENCES INC | $2.7M | 430.0K | 0.36% | — |
| 25 | ? N/A UNICYCIVE THERAPEUTICS INC | $1.3M | 275.0K | 0.17% | — |
| 26 | G GOSSAMER BIO INC | $1.1M | 96.9K | 0.15% | — |